Cited by 538Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsMemory and Neural Mechanisms

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Memory improvement following induced hyperinsulinemia in Alzheimer’s disease

Abstract

Dementia of the Alzheimer type (DAT) is accompanied by disruption in glucose regulation and utilization that may contribute to its characteristic memory impairment. Increasing glucose availability by raising plasma glucose improves memory in patients with DAT. Such memory improvement is associated with a secondary elevation in plasma insulin levels, raising the question of whether improvement is due to changes in insulin levels, independent of hyperglycemia. Distributions of insulin receptors in the hippocampus and insulin-mediated increases in glucose utilization in entorhinal cortex provide potential mechanisms for such improvement. We show that raising plasma insulin through intravenous infusion while keeping plasma glucose at a fasting baseline level produces striking memory enhancement for patients with DAT. Previous findings of hyperglycemic memory enhancement were also replicated. Patients with DAT also showed abnormal plasma levels of glucoregulatory hormones and metabolites at baseline and during metabolic manipulations. Our findings suggest that neuroendocrine factors play an important role in the pathophysiology of DAT.

Overview

Integrity signals

Registry

Crossref · 10.1016/0197-4580(95)02002-0

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 41 references

Research works printed but not linked: 3

  1. Henderson, 1994, Estrogen replacement therapy and neuropsychological performance in women with probable Alzheimer's disease: A case-control study, Neurology, 44, A158
  2. Mortel, 1994, Estrogen replacement therapy and risk of dementia, Neurology, 44, A208
  3. Paganini-Hill, 1993, Estrogen replacement and Alzheimer's disease in women, Soc. Neurosci. Abs., 19, 1046

Cited by

Sorted by citations

Items 501–536 of 536

Metadata

Authors
Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Craft, Suzanne
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
1996-01
Volume
17
Issue
1
Pages
123-130
ISSN
0197-4580 (ISSN-L)
OpenAlex
W2101048381
Cited by
538
References
41
Citations by year
2026: 9 · 2025: 32 · 2024: 45 · 2023: 28 · 2022: 21 · 2021: 29 · 2020: 42 · 2019: 25 · 2018: 17 · 2017: 8 · 2016: 8 · 2015: 10 · 2014: 6 · 2013: 17 · 2012: 17
FWCI
12.30
Type
journal article
Language
en
Open access
closed
Locations
  • Neurobiology of Aging (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1k20mh001045-01)
  • National Institute on Aging (R01-AG-10880, R01AG010880)
  • National Institute of Mental Health (MH-01045)
  • National Center for Research Resources (MO1RR00036, M01RR000036)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Keywords
Alzheimer's disease, hyperinsulinemia, memory impairment, insulin, glucose regulation, hyperglycemia, hippocampus, insulin receptor, entorhinal cortex, glucoregulatory hormones, neuroendocrine factors
MeSH terms
Aged, Alzheimer Disease, Fatty Acids, Glucagon, Humans, Hyperglycemia, Hyperinsulinism, Lactates, Memory, Norepinephrine, Psychiatric Status Rating Scales

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review